News & Updates

Show Multimedia Only

Sildenafil efficacy, safety sustained regardless of delivery method

11 Dec 2021 by

Sildenafil orally disintegrating strips (ODS) are just as effective and safe as the conventional tablet formulation for the treatment of erectile dysfunction (ED), a Thai study suggests.

11 Dec 2021

E-cigarettes raise risk of erectile dysfunction

05 Dec 2021

Electronic nicotine delivery devices (ENDS) or e-cigarettes appear to be detrimental to men, with a recent study suggesting that its use contributes to a heightened risk of erectile dysfunction.

05 Dec 2021

Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer

05 Dec 2021

Cisplatin-based adjuvant chemotherapy confers substantial survival benefit in patients with muscle-invasive bladder cancer, reports a recent meta-analysis of randomized controlled trials (RCT).

05 Dec 2021

Does statin affect performance of PSA screening?

02 Dec 2021 by

Prostate-specific antigen (PSA) screening was associated with similar decrease in incidence of advanced prostate cancer (PCa) among statin users vs nonusers, but less detection of low-grade localized tumours in the former than the latter — indicating that statin does not compromise the benefits of PSA-based screening while also conferring the benefit of less overdiagnosis of low-risk tumours.

02 Dec 2021

Is docetaxel helpful in metastatic hormone-sensitive prostate cancer?

02 Dec 2021

Treatment with docetaxel appears beneficial in patients with low- and high-burden metastatic hormone-sensitive prostate cancer, a study has shown. However, no consistent differences for overall survival are seen in subgroup analyses as regards volume of metastatic disease.

02 Dec 2021

Overall survival in metastatic renal cell carcinoma differs by race, gender, treatment

01 Dec 2021

Among patients with metastatic renal cell carcinoma, there are multiple factors that affect overall survival, including race, gender, treatment, and socioeconomic factors, as reported in a study.

01 Dec 2021

MRI/ultrasound fusion biopsy accurately detects PCa in men with intermediate PSA

19 Nov 2021

Fusion biopsy with magnetic resonance imaging and ultrasonography (MRI/US) is an efficient method of detecting clinically significant prostate cancer (csPCa) in biopsy-naïve men with prostate specific antigen (PSA) levels 4–10 ng/mL, a new study has found.

19 Nov 2021

Low carbohydrate diet lowers risk of MetS, remnant cholesterol in prostate cancer

16 Nov 2021

A low carbohydrate diet (LCD) may substantially reduce the risk of metabolic syndrome (MetS) and remnant cholesterol in patients with prostate cancer, a recent study has shown.

16 Nov 2021

Socioeconomic disparities seen in geospatial clusters of urothelial carcinoma

15 Nov 2021

Spatially related clusters of urothelial carcinoma (UC) appear to correlate with locoregional environmental exposures rather than tobacco exposure, suggests a study. Such clusters may also be associated with socioeconomic disparities.

15 Nov 2021